Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
uniQure Stock Quote

uniQure (NASDAQ: QURE)

Price as of July 24, 2024, 4:00 p.m. ET

uniQure Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
QURE -17.42% -88.00% -34.56% -45%
S&P +21.98% +84.97% +13.09% +217%

uniQure Company Info

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the Netherlands.

News & Analysis


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.